ARTICLE | Clinical News
Egen preclinical data
July 1, 2013 7:00 AM UTC
In a rat model of PAH, IV administration of a microRNA-145 inhibitor using Egen's Staramine-mPEG delivery system significantly reversed pulmonary hypertension and improved cardiovascular function. Da...